Gilead Sciences Announces Third Quarter 2017 Dividend
July 26 2017 - 04:02PM
Business Wire
Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the
company’s Board of Directors has declared a cash dividend of $0.52
per share of common stock for the third quarter of 2017. The
dividend is payable on September 28, 2017, to stockholders of
record at the close of business on September 15, 2017. Future
dividends will be subject to Board approval.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers,
develops and commercializes innovative therapeutics in areas of
unmet medical need. The company’s mission is to advance the care of
patients suffering from life-threatening diseases. Gilead has
operations in more than 30 countries worldwide, with headquarters
in Foster City, California.
For more information on Gilead Sciences, please
visit the company’s website at www.gilead.com, follow Gilead on
Twitter (@GileadSciences) or call Gilead Public Affairs at
1-800-GILEAD-5 or 1-650-574-3000.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170726006063/en/
InvestorsGilead Sciences,
Inc.Robin Washington, 650-522-5688Sung Lee, 650-524-7792
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Feb 2024 to Mar 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Mar 2023 to Mar 2024